Abstract:BACKGROUND The mammalian circadian clock and its associated clock genes are increasingly been recognized as critical components for a number of physiological and disease processes that extend beyond hormone release, thermal regulation, and sleep-wake cycles. New evidence suggests that clinical behavior disruptions that involve prolonged shift work and even space travel may negatively impact circadian rhythm and lead to multi-system disease. METHODS In light of the significant role circadian rhythm can hold over the body's normal physiology as well as disease processes, we examined and discussed the impact circadian rhythm and clock genes hold over lifespan, neurodegenerative disorders, and tumorigenesis. RESULTS In experimental models, lifespan is significantly reduced with the introduction of arrhythmic mutants and leads to an increase in oxidative stress exposure. Interestingly, patients with Alzheimer's disease and Parkinson's disease may suffer disease onset or progression as a result of alterations in the DNA methylation of clock genes as well as prolonged pharmacological treatment for these disorders that may lead to impairment of circadian rhythm function. Tumorigenesis also can occur with the loss of a maintained circadian rhythm and lead to an increased risk for nasopharyngeal carcinoma, breast cancer, and metastatic colorectal cancer. Interestingly, the circadian clock system relies upon the regulation of the critical pathways of autophagy, the mechanistic target of rapamycin (mTOR), AMP activated protein kinase (AMPK), and silent mating type information regulation 2 homolog 1 (Saccharomyces cerevisiae) (SIRT1) as well as proliferative mechanisms that involve the wingless pathway of Wnt/β-catenin pathway to foster cell survival during injury and block tumor cell growth. CONCLUSION Future targeting of the pathways of autophagy, mTOR, SIRT1, and Wnt that control mammalian circadian rhythm may hold the key for the development of novel and effective therapies against aging- related disorders, neurodegenerative disease, and tumorigenesis.

The cell cycle related rhythms, cells' states correlation and the cancer

Circadian rhythm and cell population growth

The Relationship between Circadian Rhythm and Cancer Disease

A scenario of unhealthy life cycle: The role of circadian rhythms in health

Cyclins and cdks in development and cancer: a perspective

Circadian Coupling Orchestrates Cell Growth

Multiscale modelling of tumour growth induced by circadian rhythm disruption in epithelial tissue

Circadian rhythm and its role in malignancy

Learning from circadian rhythm to transform cancer prevention, prognosis, and survivorship care

The molecular circadian rhythms regulating the cell cycle

Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.

Multiscale modeling of tumor growth induced by circadian rhythm disruption in epithelial tissue

From quiescence to proliferation: Cdk oscillations drive the mammalian cell cycle

On the design and stability of cancer adaptive therapy cycles: deterministic and stochastic models

Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer

Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.

Circadian Rhythm Disruption in Cancer Survivors: From Oncogenesis to Quality of Life

Exploring the role of circadian clock gene and association with cancer pathophysiology

Crosstalk between Circadian Rhythm Dysregulation and Tumorigenesis, Tumor Metabolism and Tumor Immune Response

The three different phases in the dynamics of chemical reaction networks and their relationship to cancer